top of page
Executive Spotlights

Boston Scientific Completes Acquisition of Relievant Medsystems, Inc.

Marlborough, MA, November 17, 2023 (PRNewswire) -- Boston Scientific Corporation (NYSE: BSX) announces the completion of its acquisition of Relievant Medsystems Inc., the sole provider of the FDA-cleared Intracept® Intraosseous Nerve Ablation System for treating vertebrogenic pain, a form of chronic low back pain. The Intracept system, a basivertebral nerve ablation therapy, enhances Boston Scientific's chronic pain portfolio, which includes spinal cord stimulation, radiofrequency ablation, and interspinous spacer procedures.


Read full article here.

Recent Posts

See All

Radiant Vision Systems Appoints new CEO

Redmond, WA, July 1, 2024 (Radiant) -- Radiant Vision Systems has appointed Stone Jiang as their new CEO, succeeding Doug Kreysar who is retiring. Jiang, previously the Executive Vice President and

Orion and Merck Secure $1.63B Agreement

Rahway, NJ, July 1, 2024 (Business Wire) -- Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, and Orion Corporation ("Orion") have agreed to convert their co-development and co-commercial

Comments


Life Science Headlines
bottom of page